145 related articles for article (PubMed ID: 19621006)
21. Drug-eluting stent for long coronary artery disease.
Park SJ; Kim YH
Indian Heart J; 2008; 60(6):519-23. PubMed ID: 19276489
[No Abstract] [Full Text] [Related]
22. ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007.
Daemen J; Simoons ML; Wijns W; Bagust A; Bos G; Bowen JM; Braunwald E; Camenzind E; Chevalier B; Dimario C; Fajadet J; Gitt A; Guagliumi G; Hillege HL; James S; Jüni P; Kastrati A; Kloth S; Kristensen SD; Krucoff M; Legrand V; Pfisterer M; Rothman M; Serruys PW; Silber S; Steg PG; Tariah I; Wallentin L; Windecker SW; Aimonetti A; Allocco D; Baczynska A; Bagust A; Berenger M; Bos G; Boam A; Bowen JM; Braunwald E; Calle JP; Camenzind E; Campo G; Carlier S; Chevalier B; Daemen J; de Schepper J; Di Bisceglie G; Dimario C; Dobbels H; Fajadet J; Farb A; Ghislain JC; Gitt A; Guagliumi G; Hellbardt S; Hillege HL; Ten Hoedt R; Isaia C; James S; de Jong P; Jüni P; Kastrati A; Klasen E; Kloth S; Kristensen SD; Krucoff M; Legrand V; Lekehal M; Lenarz L; Ni Mhullain F; Nagai H; Patteet A; Paunovic D; Pfisterer M; Potgieter A; Purdy I; Raveau-Landon C; Rothman M; Serruys PW; Silber S; Simoons ML; Steg PG; Tariah I; Ternstrom S; Van Wuytswinkel J; Waliszewski M; Wallentin L; Wijns W; Windecker SW
Eur Heart J; 2009 Jan; 30(2):152-61. PubMed ID: 19036745
[No Abstract] [Full Text] [Related]
23. Drug-eluting stents should not be used in ST-elevated myocardial infarction with cardiogenic shock.
Champion S; Gaüzère BA; Lefor Y
Arch Intern Med; 2012 Nov; 172(20):1613-4. PubMed ID: 23147461
[No Abstract] [Full Text] [Related]
24. [Drug-eluting stents: long-term safety].
Karpov IuA; Samko AN; Buza VV
Ter Arkh; 2009; 81(5):36-41. PubMed ID: 19537584
[TBL] [Abstract][Full Text] [Related]
25. ST-elevated acute myocardial infarction happening 1 month post stent implantation: late thrombosis in-stents or new lesions?
Song GY; Yang YJ; Xu B; Li JJ; Gao RL; Qiao SB; Yuan JQ; Tang YD; You SJ; Pei HJ; Zhao ZY; Wang XM; Wu YJ
Chin Med J (Engl); 2009 Jul; 122(14):1610-4. PubMed ID: 19719959
[TBL] [Abstract][Full Text] [Related]
26. [Stable coronary disease patients: more harm than benefit from heart catheter?].
Einecke D
MMW Fortschr Med; 2006 Sep; 148(38):12-4. PubMed ID: 17036952
[No Abstract] [Full Text] [Related]
27. Glucocorticoids in the prevention of in-stent restenosis: the role of inflammation.
Celik T; Iyisoy A; Barindik N; Isik E
Int J Cardiol; 2009 Jul; 135(3):403-5. PubMed ID: 18571255
[No Abstract] [Full Text] [Related]
28. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction.
Lee CW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Yun SC; Seong IW; Lee JH; Lee NH; Cho YH; Cheong SS; Lim DS; Yang JY; Lee SG; Kim KS; Yoon J; Jeong MH; Seung KB; Hong TJ; Park SJ;
Am J Cardiol; 2009 Nov; 104(10):1370-6. PubMed ID: 19892052
[TBL] [Abstract][Full Text] [Related]
29. Two-stent technique: a dead duck or alive and kicking?
Belardi JA
Catheter Cardiovasc Interv; 2009 Aug; 74(2):321-2. PubMed ID: 19642180
[No Abstract] [Full Text] [Related]
30. Drug-eluting stents for the treatment of coronary artery disease: NICE technology appraisal guidance.
Messori A; Trippoli S
Heart; 2009 May; 95(10):847. PubMed ID: 19401286
[No Abstract] [Full Text] [Related]
31. Sensory polyneuropathy associated with paclitaxel-eluting coronary stent.
Srinivasan J; Jones HR
J Neurol Sci; 2009 Sep; 284(1-2):175-6. PubMed ID: 19358999
[TBL] [Abstract][Full Text] [Related]
32. The influence of shear stress on in-stent restenosis and thrombosis.
Wentzel JJ; Gijsen FJ; Schuurbiers JC; van der Steen AF; Serruys PW
EuroIntervention; 2008 Aug; 4 Suppl C():C27-32. PubMed ID: 19202688
[No Abstract] [Full Text] [Related]
33. [Prevention of restenosis and of cardiac events after coronary angioplasty in diabetics].
Nyssen A; Legrand V; Scheen AJ
Rev Med Suisse; 2009 Aug; 5(214):1638-43. PubMed ID: 19772194
[TBL] [Abstract][Full Text] [Related]
34. NICE guidelines for the use of drug-eluting stents: how do we establish worth?
de Belder MA;
Heart; 2008 Dec; 94(12):1646-8. PubMed ID: 18728067
[No Abstract] [Full Text] [Related]
35. Late in-stent restenosis in a patient with drug-eluting stent.
Sultan FA; Kazmi K; Dhakam S; Quraishi AU
J Coll Physicians Surg Pak; 2005 Oct; 15(10):648-9. PubMed ID: 19810309
[TBL] [Abstract][Full Text] [Related]
36. Commentary on drug-eluting stents: NICE technology appraisal guidance.
Richardson J; Stevens A; Barnett D; Longson C
Heart; 2008 Dec; 94(12):1650-2. PubMed ID: 18768567
[No Abstract] [Full Text] [Related]
37. Commentary on drug-eluting stents: to use or not to use--that is the question!
Pfisterer ME
Heart; 2008 Dec; 94(12):1648-50. PubMed ID: 18782796
[No Abstract] [Full Text] [Related]
38. Stent thrombosis: a poor man's disease?
Danenberg HD; Marincheva G; Varshitzki B; Nassar H; Lotan C
Isr Med Assoc J; 2009 Sep; 11(9):529-32. PubMed ID: 19960845
[TBL] [Abstract][Full Text] [Related]
39. Stem cells show mixed results in MI patients.
Kahn J
J Interv Cardiol; 2006 Aug; 19(4):297-301. PubMed ID: 16881973
[No Abstract] [Full Text] [Related]
40. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
